Jubilant Life Sciences plans to raise Rs 1,000 crore via NCDs

28 Nov 2016 Evaluate

Jubilant Life Sciences is seeking shareholders’ approval through postal ballot/e-voting to raise up to Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. Approval to the board to raise the amount also stipulates that this could be done in one or more series/tranches during a period of one year from the date of passing the resolution.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

 

Jubilant Pharmova Share Price

937.80 -16.85 (-1.77%)
27-Jan-2026 14:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1629.20
Dr. Reddys Lab 1236.65
Cipla 1315.00
Zydus Lifesciences 888.00
Lupin 2128.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×